vs

Side-by-side financial comparison of Maplebear Inc. (CART) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

Maplebear Inc. is the larger business by last-quarter revenue ($992.0M vs $749.2M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). Maplebear Inc. runs the higher net margin — 8.2% vs 3.6%, a 4.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 12.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 10.0%).

Maplebear Inc., doing business as Instacart, is an American retail media and delivery company based in San Francisco that operates a grocery delivery and pick-up service in the United States and Canada accessible via a website and mobile app. It allows customers to order groceries, and alcohol where legal, from participating retailers with the shopping being done by a personal shopper, who picks, packs, and delivers the order.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CART vs CLOV — Head-to-Head

Bigger by revenue
CART
CART
1.3× larger
CART
$992.0M
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+49.7% gap
CLOV
62.0%
12.3%
CART
Higher net margin
CART
CART
4.5% more per $
CART
8.2%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
10.0%
CART

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CART
CART
CLOV
CLOV
Revenue
$992.0M
$749.2M
Net Profit
$81.0M
$27.3M
Gross Margin
72.3%
Operating Margin
9.9%
3.6%
Net Margin
8.2%
3.6%
Revenue YoY
12.3%
62.0%
Net Profit YoY
-45.3%
EPS (diluted)
$0.31
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CART
CART
CLOV
CLOV
Q1 26
$749.2M
Q4 25
$992.0M
$487.7M
Q3 25
$939.0M
$496.6M
Q2 25
$914.0M
$477.6M
Q1 25
$897.0M
$462.3M
Q4 24
$883.0M
$337.0M
Q3 24
$852.0M
$331.0M
Q2 24
$823.0M
$356.3M
Net Profit
CART
CART
CLOV
CLOV
Q1 26
$27.3M
Q4 25
$81.0M
$-49.3M
Q3 25
$144.0M
$-24.4M
Q2 25
$116.0M
$-10.6M
Q1 25
$106.0M
$-1.3M
Q4 24
$148.0M
$-22.1M
Q3 24
$118.0M
$-9.2M
Q2 24
$61.0M
$7.4M
Gross Margin
CART
CART
CLOV
CLOV
Q1 26
Q4 25
72.3%
Q3 25
73.7%
Q2 25
74.2%
Q1 25
74.8%
Q4 24
75.2%
Q3 24
75.2%
24.5%
Q2 24
75.7%
30.3%
Operating Margin
CART
CART
CLOV
CLOV
Q1 26
3.6%
Q4 25
9.9%
-10.1%
Q3 25
17.7%
-4.9%
Q2 25
13.6%
-2.2%
Q1 25
12.3%
-0.3%
Q4 24
17.6%
-6.4%
Q3 24
16.2%
-2.7%
Q2 24
6.3%
2.0%
Net Margin
CART
CART
CLOV
CLOV
Q1 26
3.6%
Q4 25
8.2%
-10.1%
Q3 25
15.3%
-4.9%
Q2 25
12.7%
-2.2%
Q1 25
11.8%
-0.3%
Q4 24
16.8%
-6.6%
Q3 24
13.8%
-2.8%
Q2 24
7.4%
2.1%
EPS (diluted)
CART
CART
CLOV
CLOV
Q1 26
$0.05
Q4 25
$0.31
Q3 25
$0.51
Q2 25
$0.41
Q1 25
$0.37
Q4 24
$0.53
Q3 24
$0.42
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CART
CART
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$687.0M
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.5B
$339.4M
Total Assets
$3.7B
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CART
CART
CLOV
CLOV
Q1 26
$177.6M
Q4 25
$687.0M
$78.3M
Q3 25
$1.7B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.4B
$194.5M
Q3 24
$1.3B
$288.0M
Q2 24
$1.4B
$254.8M
Stockholders' Equity
CART
CART
CLOV
CLOV
Q1 26
$339.4M
Q4 25
$2.5B
$308.7M
Q3 25
$3.5B
$340.9M
Q2 25
$3.3B
$344.2M
Q1 25
$3.2B
$336.1M
Q4 24
$3.1B
$341.1M
Q3 24
$2.9B
$342.2M
Q2 24
$3.0B
$324.9M
Total Assets
CART
CART
CLOV
CLOV
Q1 26
$697.7M
Q4 25
$3.7B
$541.0M
Q3 25
$4.5B
$559.7M
Q2 25
$4.4B
$575.0M
Q1 25
$4.3B
$583.7M
Q4 24
$4.1B
$580.7M
Q3 24
$3.9B
$653.0M
Q2 24
$4.0B
$674.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CART
CART
CLOV
CLOV
Operating Cash FlowLast quarter
$183.0M
Free Cash FlowOCF − Capex
$171.0M
FCF MarginFCF / Revenue
17.2%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
2.26×
TTM Free Cash FlowTrailing 4 quarters
$910.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CART
CART
CLOV
CLOV
Q1 26
Q4 25
$183.0M
$-66.9M
Q3 25
$287.0M
$12.1M
Q2 25
$203.0M
$5.4M
Q1 25
$298.0M
$-16.3M
Q4 24
$153.0M
$34.8M
Q3 24
$185.0M
$50.0M
Q2 24
$244.0M
$44.8M
Free Cash Flow
CART
CART
CLOV
CLOV
Q1 26
Q4 25
$171.0M
$-69.0M
Q3 25
$272.0M
$11.4M
Q2 25
$187.0M
$4.8M
Q1 25
$280.0M
$-16.5M
Q4 24
$141.0M
$33.3M
Q3 24
$171.0M
$49.6M
Q2 24
$220.0M
$44.4M
FCF Margin
CART
CART
CLOV
CLOV
Q1 26
Q4 25
17.2%
-14.1%
Q3 25
29.0%
2.3%
Q2 25
20.5%
1.0%
Q1 25
31.2%
-3.6%
Q4 24
16.0%
9.9%
Q3 24
20.1%
15.0%
Q2 24
26.7%
12.5%
Capex Intensity
CART
CART
CLOV
CLOV
Q1 26
Q4 25
1.2%
0.4%
Q3 25
1.6%
0.1%
Q2 25
1.8%
0.1%
Q1 25
2.0%
0.0%
Q4 24
1.4%
0.5%
Q3 24
1.6%
0.1%
Q2 24
2.9%
0.1%
Cash Conversion
CART
CART
CLOV
CLOV
Q1 26
Q4 25
2.26×
Q3 25
1.99×
Q2 25
1.75×
Q1 25
2.81×
Q4 24
1.03×
Q3 24
1.57×
Q2 24
4.00×
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CART
CART

Transaction$698.0M70%
Advertising And Other$294.0M30%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons